New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
07:47 EDTDSCODiscovery Labs receives new U.S. patent for pulmonary surfactant formulations
Discovery Laboratories announced it has received a patent issued by the United States Patent and Trademark Office entitled "Pulmonary Surfactant Formulations." The claims of the patent provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028.
News For DSCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
09:14 EDTDSCOOn The Fly: Pre-market Movers
Subscribe for More Information
April 16, 2015
19:00 EDTDSCOOn The Fly: After Hours Movers
Subscribe for More Information
16:49 EDTDSCODiscovery Labs terminates employment agreement of COO Thomas Miller
Subscribe for More Information
16:25 EDTDSCODiscovery Labs ceases commercialization of Surfaxin
The decision to cease the commercialization of SURFAXIN is not based on any underlying safety or efficacy concern, but rather is compelled by the company's desire to preserve capital to advance AEROSURF and the KL4 surfactant pipeline.
16:23 EDTDSCODiscovery Labs to take charge of $3.5M in Q2 on restructuring
Subscribe for More Information
16:19 EDTDSCODiscovery Labs completes enrollment of Aerosurf Phase 2a clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use